Stock 9966 ALPHAMAB ONCOLOGY
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Alphamab Oncology

Equities

9966

KYG0330A1013

Delayed Hong Kong S.E.
Other stock markets
 11:58:43 2024-06-06 pm EDT 		5-day change 1st Jan Change
2.99 HKD +3.82% Intraday chart for Alphamab Oncology +17.72% -54.97%
Jun. 05 ArriVent, Alphamab Unit to Collaborate on Antibody Drug Conjugates For Cancer Treatment MT
Jun. 05 Alphamab Strikes Deal with Nasdaq-Listed ArriVent to Co-Develop Antibody Drug Conjugates MT

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Dividend / Share (DPS) - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Dividend / Share (DPS)

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. 9966 Stock
  4. Revisions Alphamab Oncology